Pharmaceutical supply agreements
Original notice title
Germany – Pharmaceutical products – Arzneimittelverträge mit Beitrittsoption
Opportunity Score
Why this score?
Opportunity
45 / 100
Complexity
35 / 100
Risk factors
The notice explicitly states it is not a public procurement under EU directives, which may limit legal recourse and pro...
No award criteria or selection criteria are provided. The evaluation method is unknown.
No procurement documents available
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Moderate opportunityKey Facts
- EUR 39.5M estimated value
- Framework procurement
- Supplies contract
- 2 lots
- Duration until Mar 2028
- Supply of pharmaceutical products containing Lanreotide
- Supply of pharmaceutical products containing Triptorelin
Show full summary
This notice concerns framework agreements with accession option for pharmaceutical products containing active substances Lanreotide and Triptorelin. The buyer explicitly states this is not a public procurement under EU directives, but uses the open procedure form. Two lots with total estimated value of EUR 39,460,246.57. Duration 2 years from April 2026 to March 2028. Submission deadline is 1 February 2028. Only German language. No explicit award or selection criteria provided.
Risks
The notice explicitly states it is not a public procurement under EU directives, which may limit legal recourse and pro...
No award criteria or selection criteria are provided. The evaluation method is unknown.
No procurement documents available
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Technical
- Active substance must be Lanreotide or Triptorelin
- Framework agreement with accession option
- Supply to Wuppertal, Germany
Requirements may be incomplete.
Buyer
Location
Wuppertal, DEU
Website
Identifier
992-80322-57
Activity
Health
Lots (2)
LOT-0001
Lanreotid
Framework agreement for pharmaceuticals containing Lanreotide. Estimated value EUR 33,819,814.39. Place of performance: Wuppertal, Germany. Duration: 2026-04-01 to 2028-03-31.
EUR 33.8M
Estimated value
Location
Duration
Category
Deadline
Award details
Vertragsgegenständlich sind Arzneimittel, die den Wirkstoff Lanreotid enthalten.
Value note
Show original TED data
Original TED description
Vertragsgegenständlich sind Arzneimittel, die den Wirkstoff Lanreotid enthalten.
LOT-0002
Triptorelin
Framework agreement for pharmaceuticals containing Triptorelin. Estimated value EUR 5,640,432.18. Place of performance: Wuppertal, Germany. Duration: 2026-04-01 to 2028-03-31.
EUR 5.6M
Estimated value
Location
Duration
Category
Deadline
Award details
Vertragsgegenständlich sind Arzneimittel, die den Wirkstoff Triptorelin enthalten.
Value note
Show original TED data
Original TED description
Vertragsgegenständlich sind Arzneimittel, die den Wirkstoff Triptorelin enthalten.
Procurement Details
- Publication date
- 17 Feb 2026
- Languages
- German
Reference metadata
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 114335-2026
Documents (1)
Similar tenders
Germany – Site preparation work – VE111 Baustelleneinrichtung (119VM514 / Kronsh,SanDstBw,Ersatzneub. ZInstSanBw)
Poland – Advertising and marketing services – Zaplanowanie i realizacja kampanii Ministerstwa Finansów z zakresu działalności resortu finansów
France – Insurance services – Prestations de services d'assurance pour groupement le groupement hospitalier de territoire Yvelines Nord
Finland – Architectural, construction, engineering and inspection services – Tietomallikoordinaattori-, inventointimittaus- ja mallinnuspalvelujen puitejärjestely 2026-2028 (2028-2030)
Greece – Cultural event organisation services – ΛΕΙΤΟΥΡΓΙΑ ΤΟΥ ΘΕΑΤΡΟΥ ΟΛΥΜΠΙΑ ΜΑΡΙΑ ΚΑΛΛΑΣ ΜΕ ΕΞΕΙΔΙΚΕΥΜΕΝΟ ΠΡΟΣΩΠΙΚΟ
Spain – Architectural, construction, engineering and inspection services – Redacción del Proyecto Básico y de Ejecución, Redacción del Estudio de Seguridad y Salud y Dirección de Obra para la construcción del I.E.S. Nº 1 de 12+0 uds. (Fase 1) en la urbanización El Bosque de Pioz (Guadalajara).
Opportunity Score
Why this score?
Opportunity
45 / 100
Complexity
35 / 100
Risk factors
The notice explicitly states it is not a public procurement under EU directives, which may limit legal recourse and pro...
No award criteria or selection criteria are provided. The evaluation method is unknown.
No procurement documents available
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications